EU approves British, Italian, Japanese joint venture for combat aircraft
The European Union said on Monday it had approved a joint venture between BAE Systems (Holdings) Limited, Japan Aircraft Industrial Enhancement Co Ltd and Leonardo S.p.A., which will be the prime contractor and lead systems integrator for the
Global Combat Air Programme
.
The joint venture will develop a
sixth-generation combat aircraft
for use by the governments of Italy, the United Kingdom and Japan, with the potential for other sales to other jurisdictions or government buyers in the future, the European Commission said.
The companies have said they would each hold a 33.3% share and that the new firm would be headquartered in Britain and its first CEO would be from Italy.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Bridgetown: Unsold Furniture Liquidation 2024 (Prices May Surprise You)
Unsold Furniture | Search Ads
Learn More
Undo
Separately, France, Germany and Spain are working on their own next-generation fighter project, raising concerns from some in the industry who wonder if Europe can sustain two decades-long programmes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
38 minutes ago
- Time of India
A Warning, 'Wish Elon Well' and ...: 7 Things that Donald Trump has said about Elon Musk after their BIG Fight
President Donald Trump is reportedly backing off his battle with Elon Musk. According to news reports, in a telephone interview with NBC News, when asked if his relationship with Tesla and SpaceX CEO was over, Trump said, "I would assume so, yeah." "No," Trump told NBC when asked if he had any desire to repair his relationship with Elon Musk. "I have no intention of speaking to him," Trump said. Donald Trump's warning to Elon Musk The President also issued a warning amid reports that Musk could back Democratic lawmakers and candidates in the 2026 midterm elections. 'If he does, he'll have to pay the consequences for that,' Trump reportedly told NBC. Trump, however, declined to say what those consequences would be, and went on to add that he had not had discussions about whether to investigate Musk. Donald Trump: Wish Elon Musk well by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo When asked about Elon Musk, Trump said, 'Honestly, I've been so busy working on China, working on Russia, working on Iran. I'm not thinking about Elon, and I just wish him well.' Donald Trump: Wish Tesla Well, and not thought of what to do with the Tesla he bought as yet When Trump was asked about Tesla, he said, "I hope Elon Musk does well with Tesla." On being asked more pointedly what he plans to do with the Tesla he bought to support Elon Musk in March, he said he has not yet thought of it. There have been speculations that the President plans to sell his Tesla. Donald Trump is not taking the key he gifted to Elon Musk back President Trump said he won't take back the White House key he gifted to Elon Musk just days ago. Donald Trump on Elon Musk being called a drug addict: Sounds Unfair Responding to a New York Times article about Elon Musk's alleged drug use, Trump said, "I don't want to comment on this news, I don't know what his status is and I read an article in The New York Times and I thought it was, frankly it sounded very unfair to me." President Trump on canceling Elon Musk's contracts "We'll take a look at everything. He's got a lot of money. He gets a lot of subsidies, so we'll take a look at that only if it's fair for him and for the country. I would certainly think about it yeah but it has to be fair." AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
43 minutes ago
- Time of India
Ayurvedic & herbal products manufacturers in Indore ramp up production as Covid cases increase
Indore: As Covid-19 cases are witnessing an uptick, manufacturers of Ayurvedic and herbal products in Indore have ramped up their production capacities, anticipating a surge in demand for immunity-boosting products. Usually, summers remain the lean season for immunity booster syrups and tablets, but the resurgence of Covid-19 cases led to a jump in enquiries, prompting many units to prepare for increased production ahead of their usual season. Ayush Nirmata Sangh secretary Ashish Dubey said, "We are anticipating a surge in demand for immunity boosters as cases of Covid-19 again started to increase. Many units started preparations and are gradually increasing production." Another manufacturer owner of a local Ayurvedic firm Ravi Kumar said, "We saw an increase in enquiries for our immunity products. To meet this demand, we are expanding our operations to ensure we can deliver quality products to our customers promptly. Also, monsoon and winters are main demand period of Ayurvedic products when demand rises." Industry insiders noted that if the consumption of these products would not meet their expectations, they would still find a market during the monsoon and winter seasons when the demand for syrups and immunity boosters typically spikes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Ayurvedic products produced in Indore are distributed across various states in India, including Delhi, Punjab, Maharashtra, Uttar Pradesh, and Uttarakhand, according to local manufacturers. In response to the heightened demand, many manufacturing units are transitioning to automatic production processes, while others are opting for semi-automatic configurations to enhance efficiency. Indore is home to around 240 Ayurvedic medicine manufacturing units, with the total market size exceeding an impressive Rs 1000 crore, as reported by Ayush Nirmata Sangh.
Time of India
43 minutes ago
- Time of India
Procurement rules for scientific research eased
Mumbai: In a resounding shift, the ministry of finance eased a long-standing bottleneck in procurement rules that once tethered researchers to the govt e-Marketplace (GeM), now allowing them to source scientific equipment and consumables from outside it. The revision in monetary ceilings and procurement channels, officials say, required the direct intervention of Prime Minister Narendra Modi. For the scientific community, this isn't just administrative reform—it's an acknowledgment and a huge relief. "Science cannot be caged in platforms and progress cannot always be L1," said a frustrated scientist, who said procurement was running into long delays because of cost and quality issues. The spirit behind GeM portal is, in principle, noble, said most scientists—designed to uplift Indian suppliers and foster a self-reliant manufacturing ecosystem. "But behind the digital veneer of transparency and procurement lies a troubling reality." "As a scientist, I ask—what truly serves the nation? If I want to order a computer that serves my requirements today, I cannot buy one unless it is L1," said professor at the School of Biotechnology at Jawaharlal Nehru University, Binay Panda. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Most Successful Way of Intraday Trading is "Market Profile" TradeWise Learn More Undo Five amendments have been made to existing procurement rules. Vice-Chancellors and directors of India's top scientific and academic institutions no longer have to wait for clearances to procure scientific equipment and consumables for research. Under the newly eased rules, they now hold the power to approve Global Tender Enquiries—up to a staggering Rs 200 crore—if they believe the need is justified. No central nod, no extra scrutiny. Just their judgment. Similarly, the ceiling for direct purchases—those made without quotations—has been raised from Rs 1 lakh to Rs 2 lakh. And what once required a drawn-out trail of tenders—purchases from Rs 1 to 10 lakh—can now be cleared by a purchase committee for anything up to Rs 25 lakh. Additionally, the limits on limited tender enquiry have been lifted—from Rs 50 lakh to Rs 1 crore. And perhaps, most telling of all, said scientists—the need for open tenders—earlier triggered at Rs 50 lakh—will now apply only to purchases above Rs 1 crore. Minister of State for Science and Technology, Jitendra Singh, took to social media and termed this as "a landmark step" for enabling #EaseOfDoingResearch. "This will reduce delays, also enhance autonomy and flexibility for research institutions—empowering them to innovate faster," he added. Secretary of the Department of Science and Technology, Prof Abhay Karandikar, said, "It was made possible by the collective efforts of everyone, including other scientific secretaries, PSA, Department of Expenditure and Cabinet Secretariat. " Another scientist explained that in this "algorithm-driven marketplace, the lowest bidder always wins, never mind if the product fails the test of quality. What use is cost-efficiency if it sacrifices precision and most importantly, the requirements of a scientific experiment? What use is patriotism if it's only glued on?" "They don't really make these products here," added Prof Panda. "They import many parts, assemble them locally, and slap on a Make in India sticker—as if that alone sanctifies the machine." He quickly added, "If there is a good Indian product, we do not think twice. We prefer make-in-India by default—it's more affordable, support is better, and it's close by." Most scientists echoed this. However, "We don't want to buy an Indian product if science suffers. "
